Tubular Breast Cancer Stage III
4 clinical trials · Condition
◉ Watch Tubular Breast Cancer Stage III
| Record | Firm | Date |
|---|---|---|
| Denosumab as an add-on Neoadjuvant Treatment (GeparX) (NCT02682693) | GBG Forschungs GmbH | 2017-02-13 |
| A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto) (NCT02125344) | GBG Forschungs GmbH | 2014-12-01 |
| Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto) (NCT01583426) | GBG Forschungs GmbH | 2012-07-01 |
| Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer (NCT01426880) | GBG Forschungs GmbH | 2011-08-01 |
Track Tubular Breast Cancer Stage III automatically
Every clearance here is in the API, with alerts when new ones post.